Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });
2022-11-26 HKT 09:22
Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.
The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.
"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."
Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.
The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.
The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.
mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.
HashKey Capital Gains SFC Approval For In-Kind Crypto Fund Subscription
HashKey Capital received approval from the Hong Kong Securities and Futures Commission (SFC) to offer an in-kind crypto... Read more
Alibaba Launches Qwen3 AI Model With Hybrid Reasoning
Alibaba launched Qwen3, the latest generation of its open-sourced large language model (LLM) family, on 29 April 2025. ... Read more
HKMA And Cyberport Launch Second Cohort Of Gen AI Sandbox
The Hong Kong Monetary Authority (HKMA), in collaboration with the Hong Kong Cyberport Management Company Limited (Cybe... Read more
InvestHKs Global Fast Track 2025 Open For Applications
Global Fast Track 2025 (GFT 2025) is now open for applications from today, 28 April 2025, until 21 September 2025. This... Read more
Ant Group To Buy Over 50% Stake In Bright Smart Securities
Bright Smart Securities & Commodities, a Hong Kong-based brokerage, made an announcement on 26 April 2025. Its chai... Read more
InvestHK Seminar In India Spotlights Hong Kongs Strategic Business Edge
Invest Hong Kong (InvestHK), the Hong Kong Economic and Trade Office in Singapore (HKETO Singapore), and the Hong Kong ... Read more